Search Browse Earnings

Protara Therapeutics, Inc. — SlamSEC

Protara Therapeutics, Inc.

Nasdaq:TARA

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.9M

+0.0% YoY

FY 2016

Adj. EBITDA

-$49.1M

-1666.4% margin

FY 2025

Net Income

-$44.6M

-1512.8% margin

FY 2025

EPS (Diluted)

-$2.17

FY 2025

Stock Price

$5.60

-2.1%

2026-03-11

52W Range

$2.77 – $7.82

P/E Ratio

-2.6x

Market Cap

$302.9M

Cash

$162.8M

FY 2025

Total Debt

—

Net Cash

$162.8M

FY 2021

Enterprise Value

$140.1M

Debt / EBITDA

3.3x

FY 2016

EV / EBITDA

-2.9x

Employees

—